Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
Expert Opinion on Investigational Drugs|May 26, 2017
Investigational BET bromodomain protein inhibitors in early stage clinical trials for acute myelogenous leukemia (AML)Thorsten Braun, Claude GardinBlood|December 15, 2015
An update of current treatments for adult acute myeloid leukemiaHervé Dombret, Claude GardinCurrent Hematologic Malignancy Reports|March 14, 2017
Hypomethylating Agents as a Therapy for AMLClaude Gardin, Hervé DombretReviews in Clinical and Experimental Hematology|July 20, 2005
Supportive care including growth factors in myelodysplastic syndromesClaude Gardin, Pierre FenauxSeminars in Oncology|August 12, 2008
Acute myeloid leukemia in the elderlyHervé Dombret, Emmanuel Raffoux, Claude GardinCurrent Opinion in Oncology|October 9, 2009
New insights in the management of elderly patients with acute myeloid leukemiaHervé Dombret, Emmanuel Raffoux, Claude GardinJournal of Clinical Pathology|August 4, 2016
HBME-1 is expressed by erythroid precursors in early maturation stage and can be a valuable tool for evaluation of dyserythropoiesis in bone marrow core biopsy specimensRiad Arana, Daniel Lusina, Thorsten Braun, et al.The Hematology Journal : the Official Journal of the European Haematology Association|May 24, 2003
Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapyJean-Jacques Kiladjian, Claude Gardin, Michel Renoux, et al.Ejhaem|June 8, 2026
T-Cell Acute Lymphoblastic Leukemia in a Young Patient With Andersen-Tawil Syndrome Successfully and Safely Treated With Intensive Chemotherapy Including Potential Precipitating Drugs: A Case Report After 3.5 Years of Follow-upRamy Rahmé, Paule Moussounda Bamba, Thi Thuy Duong Do, et al.Clinical Lymphoma, Myeloma & Leukemia|January 23, 2016
Imatinib Increases Serum Creatinine by Inhibiting Its Tubular Secretion in a Reversible Fashion in Chronic Myeloid LeukemiaEmmanuelle Vidal-Petiot, Delphine Rea, Fidéline Serrano, et al.Pageof 8